HOME Press Releases Life Science Instrumentation Market worth 75.24 Billion USD by 2022



Life Science Instrumentation Market worth 75.24 Billion USD by 2022


The report "Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR, Microscopy), Application (Research, Clinical), End User (Pharma-Biotech Companies, Food & Beverage Industry, Hospitals) - Global Forecast to 2022", The global life science instrumentation market is projected to reach USD 75.24 Billion by 2022 from USD 54.49 Billion in 2017, at a CAGR of 6.7%. Factors such as the increased spending on pharmaceutical R&D globally, rising food safety concerns, technological advancements in analytical instruments, and funding available for life science research activities are driving the growth of this market.

                                 Download PDF Brochure     Speak to Analyst     Inquiry Before Buying

Browse 106 Market Data Tables and 76 Figures spread through 334 Pages and in-depth TOC on "Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR, Microscopy), Application (Research, Clinical), End User (Pharma-Biotech Companies, Food & Beverage Industry, Hospitals) - Global Forecast to 2022"
http://www.marketsandmarkets.com/Market-Reports/life-science-chemical-biotech-instrumentation-market-38.html
Early buyers will receive 10% customization on reports.

The next-generation sequencing (NGS) is expected to be the fastest growing technology segment during the forecast period

By technology, the NGS segment is expected to grow at the fastest CAGR during the forecast period (2017-2022). The growth of this segment can primarily be attributed to the increasing focus of key players on technological advancements in sequencing platforms and the growing applications of NGS.

By application, the research segment is expected to be the fastest growing segment

The research applications segment is expected to grow at the fastest CAGR during the forecast period. The growth of this segment can be attributed to the evolving global regulatory scenario for research data publication for analytical instrument-based researches; increasing number of research studies and growing public-private funding in the field of genomic research; and the ongoing trend of laboratory automation & integration of robotics.

North America dominated the market in 2016

Geographically, the life science instrumentation market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). North America accounted for the largest share of the market in 2017, followed by Europe. High adoption rate of novel technologies, the large number of life science research studies conducted in the region, stringent drug development regulations, increased funding for life science research activities, and the growing number of metabolomics research studies in North America are the key factors that account for the large share of the life science instrumentation market in the region.

As of 2016, the major manufacturers operating in the global market included Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bruker Corporation (US), PerkinElmer, Inc. (US), and Waters Corporation (US), Shimadzu Corporation (Japan), Illumina, Inc. (US), Siemens AG (Germany), Horiba Ltd. (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), and Hitachi High-Technologies Corporation (Japan), among others.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports